These findings, including the identification of new additional stem cell markers attenuated after MSI-1 knockdown led us to hypothesize that breast cancer cells may be vulnerable to anti-proliferative and pro-apoptotic signaling. This evidence concerns the gene MSI1 and breast carcinoma.